Efficacy News and Research

RSS
Study evaluates efficacy of drug combinations in treating colorectal cancer

Study evaluates efficacy of drug combinations in treating colorectal cancer

Phase 3 study results of simeprevir in hepatitis C patients to be presented at EASL Congress

Phase 3 study results of simeprevir in hepatitis C patients to be presented at EASL Congress

GenSight Biologics announces closing of €32 million Series A financing

GenSight Biologics announces closing of €32 million Series A financing

MentisCura launches clinical center for early detection of Alzheimer's disease, dementia

MentisCura launches clinical center for early detection of Alzheimer's disease, dementia

Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

Dual-signaling CAR T cells show potent anti-cancer activity in animal model

Dual-signaling CAR T cells show potent anti-cancer activity in animal model

KYTHERA Biopharmaceuticals presents Phase IIIb study results of ATX-101

KYTHERA Biopharmaceuticals presents Phase IIIb study results of ATX-101

Berg to present new findings on cancer treatment, Interrogative Biology Platform at AACR meeting

Berg to present new findings on cancer treatment, Interrogative Biology Platform at AACR meeting

FMT treatment improves symptoms in pediatric patients with active ulcerative colitis

FMT treatment improves symptoms in pediatric patients with active ulcerative colitis

AstraZeneca reports fostamatinib Phase 3 study results for treatment of rheumatoid arthritis

AstraZeneca reports fostamatinib Phase 3 study results for treatment of rheumatoid arthritis

India's Supreme Court ruling on drug patent will promote affordable medicines, 'preserve' innovation incentives

India's Supreme Court ruling on drug patent will promote affordable medicines, 'preserve' innovation incentives

Individualized genomic analysis allows for tailored cancer treatment, new drug research

Individualized genomic analysis allows for tailored cancer treatment, new drug research

Writing therapy is an evidence-based treatment for PTS, says study

Writing therapy is an evidence-based treatment for PTS, says study

Research: Hepatitis A virus steals membranes from infected cells to protect it from antibodies

Research: Hepatitis A virus steals membranes from infected cells to protect it from antibodies

Emergent BioSolutions provides update on TRU-016 Phase 1b study

Emergent BioSolutions provides update on TRU-016 Phase 1b study

UIC College of Pharmacy receives grant to train students in natural product drugs

UIC College of Pharmacy receives grant to train students in natural product drugs

BioInvent International presents clinical results of BI-505 at myeloma workshop in Kyoto

BioInvent International presents clinical results of BI-505 at myeloma workshop in Kyoto

Scientists develop a new way to generate induced pluripotent stem cell lines from human fibroblasts

Scientists develop a new way to generate induced pluripotent stem cell lines from human fibroblasts

Tris Pharma gets FDA NDA approval for Karbinal ER Extended-release Oral Suspension

Tris Pharma gets FDA NDA approval for Karbinal ER Extended-release Oral Suspension

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.